Congratulations to @basemcc on the 2024 SAMBA Distinguished Service Award 🥇! Thank you for your steadfast leadership and commitment to advancing our specialty. #samba24@sambahq
Looking for a great fellowship in #Anesthesiology that will prepare you for future- look at @YAnesthesiology Head and Neck fellowship a 1 yr non-ACGME w/unparalleled mentorship and concentrated exposure to mgmt difficult airway https://t.co/CYWAvpS7qs
My pinned tweet is “always use regional anesthesia, sometimes” . This is why, We have to follow the science and adjust our practice based on evidence and the patient in front of us. We have access to more data now than ever before. I applaud Dr Sites for his candid editorial.
@EduMed_UK @Anaes_Journal Also it has a long half-life compared to the other anti-dopaminergic agents we have in our armamentarium and works on other receptors important for PONV as well
I've been anxiously awaiting the results of this study. So excited to see it published @Anaes_Journal ! When added to TIVA, dexamethasone, and ondansetron, olanzapine reduced the risk of #PONV with large effect size https://t.co/3PJOghhwv9
@EduMed_UK @Anaes_Journal Not sure if the authors looked at QTc, not reported in the manuscript however there is some evidence that QTc prolongation may be less significant for Olanzapine compared to other antipsychotics https://t.co/d3QtZA0qKi
🔓Flexible nasal bronchoscopy vs. Airtraq® videolaryngoscopy for awake tracheal intubation: a randomised controlled non-inferiority study.
This great new paper is now #FreeForAWeek!
🔗https://t.co/nZiSupo14d
For intubations with DL in the OR, need for rescue with an alternate device was rare, and even rarer with single-use vs. reusable laryngoscopes @shanasociety @MountSinaiAnes1 https://t.co/jrQYx0CqSD